Standard: AAMI 10993-17
BIOLOGICAL EVALUATION OF MEDICAL DEVICES - PART 17: METHODS FOR THE ESTABLISHMENT OF ALLOWABLE LIMITS FOR LEACHABLE SUBSTANCES
This standard is available for individual purchase.
IHS Standards Expert subscription, simplifies and expedites the process for finding and managing standards by giving you access to standards from over 370 standards developing organizations (SDOs).FEATURES & BENEFITS
- Maximize product development and R&D with direct access to over 1.6 million standards
- Discover new markets: Identify unmet needs and discover next-generation technologies
- Improve quality by leveraging consistent standards to meet customer and market requirements
- Minimize risk: Mitigate liability and better understand compliance regulations
- Boost efficiency: Speed up research, capture and reuse expertise
HOW TO SUBSCRIBE
This part of ISO 10993 specifies the method for the determination of allowable limits for substances leachable from medical devices. It is intended for use in deriving standards and estimating appropriate limits where standards do not exist. It describes a systematic process through which identified risks arising from toxicologically hazardous substances present in medical devices can be quantified.
This part of ISO 10993 is not applicable to devices that have no patient contact (e.g., in vitro diagnostic devices).
Exposure to a particular chemical substance may arise from other sources other than the device, such as food, water, or air. This part of ISO 10993 does not address the potential for exposure from such sources.
|Organization:||Association for the Advancement of Medical Instrumentation|
|Document Number:||aami 10993-17|
|Most Recent Revision:||YES|
|Document #||Change Type||Update Date||Revision||Status|
|AAMI 10993-17||Change Type: REAF||Update Date: 2002-01-01||Revision: 02||Status: ACTV|
|AAMI 10993-17||Change Type:||Update Date: 2002-01-01||Revision: 02||Status: ACTV|